Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL.

MLA

Korell, Felix, et al. “Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL.” Cells (2073-4409), vol. 9, no. 5, May 2020, p. 1225. EBSCOhost, https://doi.org/10.3390/cells9051225.

APA

Korell, F., Laier, S., Sauer, S., Veelken, K., Hennemann, H., Schubert, M.-L., Sauer, T., Pavel, P., Mueller-Tidow, C., Dreger, P., Schmitt, M., & Schmitt, A. (2020). Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL. Cells (2073-4409), 9(5), 1225. https://doi.org/10.3390/cells9051225

Chicago

Korell, Felix, Sascha Laier, Sandra Sauer, Kaya Veelken, Hannah Hennemann, Maria-Luisa Schubert, Tim Sauer, et al. 2020. “Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL.” Cells (2073-4409) 9 (5): 1225. doi:10.3390/cells9051225.